REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/28/2026
Back to search
Official data from USPTO
AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS
ST13
US500000086868434Class
35
Filing
86868434
Registration
5149162
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
03/01/2026
Trademark type
Word
Nice classes
35
Filing date
01/07/2016
Registration date
02/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/25/2023
Last transaction
03/01/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
1969-00-00
First use in commerce
1969-00-00
Drawing code
4
Owner type
99
Owner location
Alexandria, VA, US
Examiner
GLASSER, CARYN
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
American Society for Clinical Pharmacology & Therapeutics
Representatives
Gregory M. Stone Whiteford Taylor & Preston Llp
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Association servicespromoting the interests of professionals whose primary interest is to advance the science and practice of clinical pharmacology and translational medicine for the therapeutic benefit of patients and society
Publications
History of USPTO decisions and trademark events.
21 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/25/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/25/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/25/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/27/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/13/2016
PUBO
PUBLISHED FOR OPPOSITION
12/13/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2016
GNRT
NON-FINAL ACTION E-MAILED
04/28/2016
CNRT
NON-FINAL ACTION WRITTEN
04/28/2016
DOCK
ASSIGNED TO EXAMINER
04/22/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
01/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2016
NWAP
NEW APPLICATION ENTERED
01/11/2016
Continuous trademark protection
Get notified about every new filing that threatens AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.